Yahoo Web Search

Search results

1. • 

     Is Eli Lilly And Co (NYSE:LLY) the Best Weight Loss Stock to Buy in 2024?

     Insider Monkey via Yahoo Finance· 4 days ago

     We recently published a list of Jim Cramer’s Top 10 Stock Picks for June. Since Eli Lilly And Co...

2. • 

     This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors | The Motley Fool

     The Motley Fool· 2 days ago

     Eli Lilly (LLY 0.65%) and Novo Nordisk (NVO 1.87%) are the two most valuable healthcare companies in...

3. • 

     Weight-loss drug shortages lead to tracker from startup - Indianapolis Business Journal

     Indianapolis Business Journal· 6 days ago

     Shortages of weight-loss drugs like Wegovy and Eli Lilly and Co.’s Zepbound have led telehealth ...

4. • 

     Eli Lilly Plans $5.3B Expansion of Pharmaceutical Manufacturing Facility in Lebanon, Indiana

     REBusinessOnline.com· 7 days ago

     LEBANON, IND. — Eli Lilly and Co. (NYSE: LLY) has released plans for a $5.3 billion expansion of its...

5. • 

     Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate | The Motley Fool

     The Motley Fool· 13 hours ago

     Investors interested in the pharmaceutical industry are currently excited about the anti-obesity...

6. • 

     Mounjaro vs. Ozempic: Is One Better Than the Other For Weight Loss?

     MediaFeed via AOL· 5 days ago

     In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...

7. • 

     Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows By Reuters

     Investing.com· 7 days ago

     Global spending on obesity medications totaled $24 billion last year, IQVIA estimated in its latest...

8. • 

     Amazon is expanding its pharmacy footprint

     Quartz· 6 hours ago

     After struggling to find its foothold in the U.S. healthcare market since its launch in 2020, in March Amazon announced a partnership with Eli Lilly to...

9. • 

     Structure Therapeutics Stock Soars on Obesity Pill Data

     The Wall Street Journal· 11 hours ago

     Structure’s once-daily drug, code-named GSBR-1290, helped people lose an average of more than 6% of...

10. • One Ozempic patient reveals major drug-powered weight loss truths

      TheStreet.com· 3 days ago

      As medicines for losing weight become more widely accessed and affordable, people are discussing their experiences. Pharmaceutical companies such as Eli ...